Tissue Repair & Recovery Research
Cytoprotective Peptides, Stacks & Immune Support
The most research-dense category in the library. BPC-157 and TB-500 anchor a comprehensive lineup of repair, immune, and matrix-remodeling compounds — each addressing a distinct biological mechanism in the healing process.
At a Glance
Tissue repair research spans multiple biological mechanisms: angiogenesis, cell migration, collagen synthesis, anti-inflammatory signaling, antimicrobial defense, and immune modulation. No single compound covers all of these — which is why stacks like the Wolverine Stack, GLOW Mix, and Klow Mix exist. Understanding each compound's mechanism helps researchers select the right combination for their specific tissue model.
The most extensively studied cytoprotective peptide — 100+ preclinical studies across tendon, gut, CNS, muscle, and angiogenesis. Oral bioavailability confirmed. The benchmark compound for tissue repair research.
100+ Preclinical Studies · Read overview →Systemic actin-regulating peptide that mobilizes cells toward injury sites regardless of injection location. The systemic complement to BPC-157's localized action.
80+ Preclinical Studies · Read overview →Naturally occurring copper-binding tripeptide that modulates 4,000+ human genes. Drives collagen/elastin synthesis, delivers bioavailable copper, and reduces fibrosis.
Preclinical + Cosmetic · Read overview →C-terminal alpha-MSH fragment. Directly inhibits NF-κB without broad immunosuppression. Oral bioavailability confirmed. IBD, gut barrier, skin inflammation research.
Growing Preclinical · Read overview →The most cited tissue repair combination in preclinical research. BPC-157's local cytoprotection paired with TB-500's systemic cell mobilization — two non-overlapping mechanisms covering the full repair spectrum.
Combined 180+ Studies · Read overview →Wolverine Stack plus GHK-Cu's collagen synthesis and gene expression layer. Maximum regenerative coverage — repair mechanics, systemic mobilization, and matrix remodeling simultaneously.
Read overview →Anti-inflammation-first repair stack. KPV resolves NF-κB-driven inflammation; BPC-157 supports repair; GHK-Cu remodels the matrix. Fully oral protocol possible — ideal for gut and skin inflammation research.
Read overview →Copper tripeptide with specific affinity for dermal papilla tissue. Activates Wnt/β-catenin signaling for anagen phase extension. GHK-Cu's follicle-focused analogue.
Preclinical + Cosmetic · Read overview →Primary active thymic peptide approved in 37+ countries for hepatitis B and C. Modulates T-cell maturation and dendritic cell activation. COVID-19 mortality reduction data from Chinese trials.
Approved 37+ Countries · Read overview →Helix B peptide of erythropoietin activating the innate repair receptor without erythropoiesis. Phase 2 data in small fiber neuropathy — pain reduction and nerve fiber regeneration.
Phase 2 Clinical · Read overview →The only human cathelicidin. Kills antibiotic-resistant bacteria and disrupts biofilms via membrane disruption. Simultaneously coordinates innate immune response and wound healing.
Substantial Preclinical + Clinical · Read overview →All compounds listed are for laboratory research use only. Not for human or veterinary use. Information based on publicly available scientific literature as of 2026. · Helixera Labs LLC © 2026